CRNO TO1 B - Cereno Scientific AB News Story
SEK0.395 -0.0 -3.7%
Last Trade - 05/03/21
| Market Cap | £11.5m |
| Enterprise Value | £6.71m |
| Revenue | £n/a |
| Position in Universe | 1532nd / 1850 |
BRIEF-Cereno Scientific And OCT Sign Contract For Phase II Study In Patients Undergoing Knee Replacement
Wed 12th September, 2018 9:04am
Sept 12 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC AND OCT SIGN CONTRACT FOR THE CONDUCT OF A PHASE II STUDY IN PATIENTS
UNDERGOING KNEE REPLACEMENT
* APPLICATIONS TO REGULATORY AUTHORITIES TO CONDUCT STUDY ARE EXPECTED TO BE SUBMITTED IN Q4
2018
Source text for Eikon: ID:nWkr1YBmBq
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cereno Scientific AB
See all news
